Bromocriptine mesylate (Cycloset) for type 2 diabetes mellitus

Am Fam Physician. 2013 May 15;87(10):718-20.
No abstract available

Publication types

  • Review

MeSH terms

  • Bromocriptine / adverse effects
  • Bromocriptine / therapeutic use*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dopamine Agonists / adverse effects
  • Dopamine Agonists / therapeutic use*
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Treatment Outcome

Substances

  • Dopamine Agonists
  • Hypoglycemic Agents
  • Bromocriptine